TARGETED THERAPY IN CANCER

Por Tsimberidou, Apostolia-Maria
Publicado no Cancer Chemother Pharmacol (2015)

Dasatinib in chronic myeloid leukemia: a review

Por Aguilera, Dolly G, Tsimberidou, Apostolia M
Publicado em 2009

Managing Cardiac Risk Factors in Oncology Clinical Trials

Por Tsimberidou, Apostolia-Maria, Minotti, Giorgio, Cardinale, Daniela
Publicado em 2011

Anti-Vascular Endothelial Growth Factor Therapies and Cardiovascular Toxicity: What Are the Important Clinical Markers to Target?

Por Vaklavas, Christos, Lenihan, Daniel, Kurzrock, Razelle, Tsimberidou, Apostolia Maria
Publicado em 2010

Cardiovascular Toxicity Profiles of Vascular-Disrupting Agents

Por Subbiah, Ishwaria M., Lenihan, Daniel J., Tsimberidou, Apostolia M.
Publicado em 2011

Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing

Por Janku, Filip, Kaseb, Ahmed O., Tsimberidou, Apostolia M., Wolff, Robert A., Kurzrock, Razelle
Publicado em 2014

Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression

Por Vaklavas, Christos, Sotelo-Rafiq, Elsa P, Lovy, Jordan, Escobar, Miguel A, Tsimberidou, Apostolia M
Publicado em 2010

Antibody-independent isolation of circulating tumor cells by continuous-flow dielectrophoresis

Por Shim, Sangjo, Stemke-Hale, Katherine, Tsimberidou, Apostolia M., Noshari, Jamileh, Anderson, Thomas E., Gascoyne, Peter R. C.
Publicado em 2013

A pilot study of temsirolimus and body composition

Por Veasey-Rodrigues, Heloisa, Parsons, Henrique A., Janku, Filip, Naing, Aung, Wheler, Jennifer J., Tsimberidou, Apostolia M., Kurzrock, Razelle
Publicado em 2013

Anti-tumor response to combined anti-angiogenic and cytotoxic chemotherapy in recurrent metastatic chromophobe renal cell carcinoma: Response signatures and Proteomic Correlates

Por Maiti, Abhishek, Brown, Robert E., Corn, Paul G., Murthy, Ravi, Ganeshan, Dhakshina Moorthy, Tsimberidou, Apostolia M., Subbiah, Vivek
Publicado no Clin Genitourin Cancer (2015)

BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes

Por El-Osta, Hazem, Falchook, Gerald, Tsimberidou, Apostolia, Hong, David, Naing, Aung, Kim, Kevin, Wen, Sijin, Janku, Filip, Kurzrock, Razelle
Publicado em 2011

Evaluation of the Clinical Relevance of Body Composition Parameters in Patients with Cancer Metastatic to the Liver Treated with Hepatic Arterial Infusion Chemotherapy

Por Parsons, Henrique A., Tsimberidou, Apostolia M., Pontikos, Michael, Fu, Siqing, Hong, David, Wen, Sijin, Baracos, Vickie E., Kurzrock, Razelle
Publicado em 2012

A Phase I Study of Hepatic Arterial Infusion of Nab-Paclitaxel in Combination with Intravenous Gemcitabine and Bevacizumab for Patients with Advanced Cancers and Predominant Liver...

Por Tsimberidou, Apostolia M., Ye, Yang, Wheler, Jennifer, Naing, Aung, Hong, David, Nwosu, Uchechi, Hess, Kenneth R., Wolff, Robert A.
Publicado em 2013

Phase I Clinical Trial Outcomes in 93 Patients with Brain Metastases: The MD Anderson Cancer Center Experience

Por Tsimberidou, Apostolia Maria, Letourneau, Katherine, Wen, Sijin, Wheler, Jennifer, Hong, David, Naing, Aung, Iskander, Nancy G., Uehara, Cynthia, Kurzrock, Razelle
Publicado em 2011

Outcomes of Research Biopsies in Phase I Clinical Trials: The MD Anderson Cancer Center Experience

Por El-Osta, Hazem, Hong, David, Wheler, Jennifer, Fu, Siqing, Naing, Aung, Falchook, Gerald, Hicks, Marshall, Wen, Sijin, Tsimberidou, Apostolia M., Kurzrock, Razelle
Publicado em 2011

Phase 1 Clinical Trials in 83 Patients With Pancreatic Cancer: The M. D. Anderson Cancer Center Experience

Por Vaklavas, Christos, Tsimberidou, Apostolia-Maria, Wen, Sijin, Hong, David, Wheler, Jennifer, Ng, Chaan S., Naing, Aung, Uehara, Cynthia, Wolff, Robert A., Kurzrock, Razelle
Publicado em 2010

Chemoimmunotherapy May Overcome the Adverse Prognostic Significance of 11q Deletion in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Por Tsimberidou, Apostolia-Maria, Tam, Constantine, Abruzzo, Lynne V., O'Brien, Susan, Wierda, William G., Lerner, Susan, Kantarjian, Hagop M., Keating, Michael J.
Publicado no Cancer (2009)

PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers

Por Janku, Filip, Lee, J. Jack, Tsimberidou, Apostolia M., Hong, David S., Naing, Aung, Falchook, Gerald S., Fu, Siqing, Luthra, Rajyalakshmi, Garrido-Laguna, Ignacio, Kurzrock, Razelle
Publicado em 2011

Phase I clinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvement

Por Tsimberidou, Apostolia M., Letourneau, Katherine, Fu, Siqing, Hong, David, Naing, Aung, Wheler, Jennifer, Uehara, Cynthia, McRae, Stephen E., Wen, Sijin, Kurzrock, Razelle
Publicado em 2010

Phase I Study of BIIB028, a selective heat shock protein 90 inhibitor, in patients with refractory metastatic or locally advanced solid tumors

Por Hong, David, Said, Rabih, Falchook, Gerald, Naing, Aung, Moulder, Stacy, Tsimberidou, Apostolia-Maria, Galluppi, Gerald, Dakappagari, Naveen, Storgard, Chris, Kurzrock, Razelle, Rosen, Lee S.
Publicado em 2013